scispace - formally typeset
W

Wei Wang

Researcher at Tsinghua University

Publications -  48
Citations -  1548

Wei Wang is an academic researcher from Tsinghua University. The author has contributed to research in topics: Daucosterol & Topic model. The author has an hindex of 20, co-authored 48 publications receiving 1346 citations. Previous affiliations of Wei Wang include Chongqing University & Shandong University.

Papers
More filters
Journal ArticleDOI

Alkaloids from Portulaca oleracea L.

TL;DR: Five alkaloids (oleraceins A, B, C, D and E) were isolated from Portulaca oleracea L., and their structures determined by spectroscopic methods as 5-hydroxy-1-p-coumaric acyl-2,3-dihydro-1H-indole-2-carboxylic acid-6-O-beta-D-glucopyranoside, 5- hydroxy-1
Journal ArticleDOI

Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract.

TL;DR: The pharmacokinetic profile indicates that ellagic acid has poor absorption and rapid elimination after oral administration pomegranate leaf extract, and part of it was absorbed from stomach.
Journal ArticleDOI

Bioactive compounds from the seeds of Punica granatum (pomegranate).

TL;DR: Two new compounds were isolated from the seeds of Punica granatum (pomegranate) together with five known compounds, which exhibited antioxidant activity, which was evaluated by measurement of low-density lipoprotein (LDL) susceptibility to oxidation and by determination in vitro of malondialdehyde levels in the rat brain.
Journal ArticleDOI

Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells

TL;DR: Results indicated that Canagliflozin might exert anti‐inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells.
Journal ArticleDOI

Hypolipidemic mechanisms of Ananas comosus L. leaves in mice: different from fibrates but similar to statins.

TL;DR: Results suggest that Ananas comosus L. leaves (AC) will be a new potential natural product for the treatment of hyperlipidemia that exerts its actions through mechanisms of inhibiting HMGCoA reductase and activating LPL activities.